Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/2010
06/09/2010CN101724144A Novel multi-arm polyethylene glycol, preparation method and application thereof
06/09/2010CN101724075A Remodeling and glycoconjugation of peptides
06/09/2010CN101723857A Lipid prodrug of drug containing guanidino and pharmacosome thereof
06/09/2010CN101721718A Lipid microbubble and preparation method thereof
06/09/2010CN101721717A Method for preparing Fe2O3 nano particle with core-shell structure
06/09/2010CN101721715A Compound of tumor targeted nonviral gene vector and plasmid DNA and preparation method thereof
06/09/2010CN101721714A Passive targeting antitumor prodrug of solid tumor and preparation method thereof
06/09/2010CN101721713A Cyclodextrin inclusion compound of 3,5-dyhydroxyl-4-isopropyl toluylene and preparation method thereof
06/09/2010CN101721712A Double-chain polyethylene glycol-insulin compound and preparation method thereof
06/09/2010CN101721711A Method for preparing phenanthroline ruthenium cyclodextrin-adamantane pyrene-single wall carbon nanometer pipe ternary ultramolecular system and application thereof
06/09/2010CN101721710A Cholesteryl-carboxymethyl Curdlan nanometer particle and preparing method
06/09/2010CN101721709A Calcium phosphate and amphiphilic polymer composite medicament-carrying nano-microsphere, preparation method and application
06/09/2010CN101721708A ED-71 preparation
06/09/2010CN101721707A Preparation method of pH response drug release carrier on basis of coordinate bond
06/09/2010CN101721702A Formulation of human antibodies for treating TNF-alpha associated disorders
06/09/2010CN101721700A Lyophilized preparation of anti-human Her2 antibody
06/09/2010CN101721687A Insulin-hydroxyapatite nano compound, preparation method and application thereof
06/09/2010CN101721685A Animal interferon liquid spray and preparation method thereof
06/09/2010CN101721684A Immunowakeup microsystem as well as preparation method and application thereof
06/09/2010CN101721677A Thymopentin oral microsphere preparation and preparation method thereof
06/09/2010CN101721594A Chinese medicinal ointment with antibacterial and antipruritic effects and preparation method thereof
06/09/2010CN101721500A Composition and preparation method and application thereof
06/09/2010CN101721456A Antiatherosclerotic Chinese traditional medicine for treating cardiovascular and cerebrovascular diseases and method for preparing phospholipid complex formulation thereof
06/09/2010CN101721444A Saussurea involucrate self-micro-emulsion, preparation method thereof and application thereof
06/09/2010CN101721431A Compound nano pearl starch ball and production process thereof
06/09/2010CN101721429A Application of amniotic epithelial cells and cell preparations thereof
06/09/2010CN101721418A External composition containing [gamma]-oryzanol
06/09/2010CN101721416A Huperzine A solid composition and preparation method thereof
06/09/2010CN101721410A Solid medicinal composition of clopidogrel hydrogen sulfate
06/09/2010CN101721407A Compound articaine hydrochloride injection and preparation method thereof
06/09/2010CN101721406A Clathrate compound of bystolic or pharmaceutical salt of bystolic, preparation method thereof and use thereof
06/09/2010CN101721400A Action of ferulic acid on enhancing drug effect of some medicaments and purpose thereof
06/09/2010CN101721391A Method for preventing cell-carrying sodium alginate microcapsule from shrinking
06/09/2010CN101721390A Method for industrially preparing sodium alginate micro-capsule loading high-density cells
06/09/2010CN101721387A Calcium carbonate effervescing agent and preparation method thereof
06/09/2010CN101721382A Lansoprazole submicron emulsion solid preparation and novel application thereof
06/09/2010CN101721380A Method for preparing sustained-release preparation
06/09/2010CN101721378A Method for preparing cefmenoxime hydrochloride freeze-dried powder injection
06/09/2010CN101721377A Method for preparing microspheres with solid-in-oil-in-hydrophilic oil-in-ethanol
06/09/2010CN101721376A Calcitonin sustained release microsphere composition and preparation method thereof
06/09/2010CN101721375A Insulin slow release micron sphere composition and preparation method thereof
06/09/2010CN101721373A Solid cefdinir sub-microemulsion and new application thereof
06/09/2010CN101721372A Gold shell coated hollow mesoporous silicon dioxide spheres, method for preparing same and application thereof in tumor treatment
06/09/2010CN101721371A Cefetamet pivoxil hydrochloride submicron emulsion solid preparation and new application thereof
06/09/2010CN101721370A Goserelin release microsphere preparation, preparation method and detecting method thereof
06/09/2010CN101721368A Medicinal composition for aerosol
06/09/2010CN101721366A Components and preparation method of beta-lactam injection
06/09/2010CN101721365A Levulose liposome injection and novel application thereof
06/09/2010CN101721364A Aqueous dispersion of camptothecin analogue-phospholipid complex and method for preparing same
06/09/2010CN101721362A Antibody-containing solution pharmaceuticals
06/09/2010CN101721360A Urapidil fructose injection and preparation method thereof
06/09/2010CN101721359A Potassium dehydroandrogrpholide succinate injection and preparation method thereof
06/09/2010CN101721358A Eye drops containing recombinant human keratinocyte growth factor-2 and application thereof in treating xeroma
06/09/2010CN101721356A Surfactant-free ginkgolide B injection
06/09/2010CN101721354A Ocular implant made by a double extrusion process
06/09/2010CN101721353A Stable thermosensitive gelatin composite
06/09/2010CN101721352A Glass slow-release conduit of fat-soluble medicine
06/09/2010CN101721351A Solid dispersion of bystolic or pharmaceutical salt of bystolic, preparation method thereof and use thereof
06/09/2010CN101721350A Folate-mediated targeted polymeric micelle
06/09/2010CN101444495B Vitamin E microcapsule preparation method
06/09/2010CN101390828B Anticancer composition loaded with anti-metabolism medicine and synergist thereof
06/09/2010CN101385703B Cation adhesion type natamycin nano eye drops
06/09/2010CN101361715B Preparation method of drug-carrying hydroxylapatite microspheres and bone cement composite porous microspheres
06/09/2010CN101342156B Gernebcin inhalation dust cloud agent
06/09/2010CN101336886B Soluble preparation of breviscapine
06/09/2010CN101301477B Isoquercitrin clathrate and preparation thereof
06/09/2010CN101297973B Highly bioadhesive and thermosensitive hydrogel, and preparation method and application thereof
06/09/2010CN101297795B Compound florfenicol powder for animals and preparation thereof
06/09/2010CN101278924B Meclofenoxate hydrochloride microcapsule and method for preparing injection thereof
06/09/2010CN101278921B Triopisetron Hydrochloride microcapsule and method for preparing injection
06/09/2010CN101278897B Process for preparing brevifolin solid lipid nano particle
06/09/2010CN101269219B Method for preparing oligose absorbent charcoal carrier sustained-release agent
06/09/2010CN101259098B Long-acting low molecule heparin intraocular sustained-release system
06/09/2010CN101255222B P(LA-MAA-EG) degradable pH responsive water gel copolymer
06/09/2010CN101244187B Suppository for treating gynaecologic disease
06/09/2010CN101229122B Zanamivir nasal in situ jellies with phase variation property and preparing method thereof
06/09/2010CN101219220B Remifentanil polymer sustained-release analgesic and its preparing process
06/09/2010CN101194923B Novel medicament for treating systematic lupus erythematosus
06/09/2010CN101161236B Method of producing drug-carrying nanometer particle of complex coacervation technics in microemulsion
06/09/2010CN101130067B Preparation for replenishing collagen and method of preparing the same
06/09/2010CN101129513B Method for preparing crataegutt sustained-release formulation by using separation - formulated product coupling technique
06/09/2010CN101095735B Preparation method of Chinese traditional medicine soft capsules for relieving cough
06/09/2010CN101032589B Gynaecological inflammation-treating medicine and its preparation
06/09/2010CN101018798B Crystalline maltitol powder less prone to consolidation and method for production thereof
06/08/2010US7732655 Controlled release therapeutic wound dressings
06/08/2010US7732628 Such as 4-[8-(2-cyanoethyl-N,N-diisopropylphosphoramidyloxy)-2-aza-1-oxooct-1-yl]benzaldehyde, 4-[8-(2-cyanoethyl-N,N-diisopropylphosphoramidyloxy)-2-aza-1-oxooct-1-yl]acetophenone; for incorporation into oligonucleotides during immobilization and conjugation of biopolymers in solid phase synthesis
06/08/2010US7732587 for treatment of TNF-mediated diseases, particularly including chronic inflammatory diseases
06/08/2010US7732492 tablet comprising disintegrant such as carmellose, sodium carboxymethyl starch, croscarmellose sodium, crospovidone, partly pregelatinized starch and low-substituted hydroxypropyl cellulose
06/08/2010US7732490 Treating non-Hodgkin's lymphoma with suberoylanilide hydroxamic acid (SAHA, vorinostat)
06/08/2010US7732489 Topical emulsion-gel composition comprising diclofenac sodium
06/08/2010US7732474 Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation
06/08/2010US7732454 Inhibitors of Bruton's tyrosine kinase
06/08/2010US7732450 Antifungal ketoconazole composition for topical use
06/08/2010US7732439 Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy
06/08/2010US7732431 for inducing contraception; for treating menopause; thermoformed packages
06/08/2010US7732415 Topical treatment or prevention of ocular infections
06/08/2010US7732411 Methods of therapy with thrombin derived peptides
06/08/2010US7732405 comprising a stabilizing benzamidine compound for control the chemical and/or physical degradation products such as enzymatic degradation or autocatalysis products; in air-tight container, antioxidant-free
06/08/2010US7732399 complexes composed of a protein or peptide and a gallic acid ester that allow for sustained delivery of the protein or peptide in vivo upon administration of the complex; gallic acid ester is epigallocatechin gallate; for drug delivery
06/08/2010US7732200 Using chondroitin sulfate proteoglycan (CSPG)-degrading enzymes mixture to propagate nervous system tissue in culture for use as tissue targeted tools in treatment of brain and neurodegenerative disorders
1 ... 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 ... 1712